The decision by a Minnesota children’s hospital to resume sex change procedures for minors directly challenges President Trump’s executive order aimed at prohibiting such practices. Signed earlier this year, the “Protecting Children from Chemical and Surgical Mutilation” Executive Order articulates the federal stance against funding procedures that transition minors from one sex to another. The order explicitly states that the U.S. will not support these procedures and emphasizes the destructive nature of the surgeries involved.
In the backdrop of this decision is a legislative push spearheaded by former Representative Marjorie Taylor Greene. Last year, Greene’s Protect Children’s Innocence Act successfully passed through the House, proposing criminal charges against those providing sex-change surgeries and hormonal treatments to minors. The bill aimed to hold parents accountable for consenting to such procedures. However, the Senate, under Republican leadership, failed to bring the bill to a vote, demonstrating a significant roadblock in efforts to codify these protections at the federal level.
The situation took a turn when a federal judge sided with 21 blue states that contested Trump’s authority to ban gender-affirming care through executive action. United States District Court Judge Mustafa Kasubhai ruled that the executive branch lacked the necessary authority, emphasizing the need for a Congressional framework to enable such a ban. This landmark ruling paved the way for hospitals like Children’s Minnesota to renew their programs.
As the hospital announced its decision to resume services in its Gender Health program, it cited the need to provide science-based health care to transgender and gender-diverse youth. A spokesperson remarked, “Offering science- and research-based health care to transgender and gender diverse youth is part of Children’s Minnesota’s vision of being every family’s essential partner in raising healthier children.” This statement highlights the hospital’s intent to prioritize the health needs of children while emphasizing a commitment to research-driven practices.
In February, amid rising scrutiny and federal actions targeting gender-affirming care, Children’s Minnesota temporarily paused its prescriptions for puberty-suppressing medications and hormones for patients under 18. This pause was described as a necessary protective measure for both healthcare providers and the institution itself. The hospital’s recent resumption of services indicates a significant shift, as it no longer aligns with the framework set forth in Trump’s executive order.
This clash between federal directives and state-level actions surrounding gender-affirming care illustrates a deepening divide in the national conversation about youth health care. The Trump Administration’s recent lawsuit against Minnesota for allowing boys to compete in girls’ sports and access girls’ facilities adds another layer to the ongoing conflict over gender identity policies.
Overall, the resumption of procedures by Children’s Minnesota signifies a broader trend among states to assert their authority in matters of health care for minors. While President Trump’s executive order aimed to consolidate federal control over such procedures, the ruling by the federal court effectively undermines that objective, leaving room for hospitals to chart their own course in a contentious and polarized environment.
"*" indicates required fields
